An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains

Int J Mol Sci. 2022 Oct 18;23(20):12457. doi: 10.3390/ijms232012457.

Abstract

Gram-negative bacteria were reported as a significant cause of infections in both community and nosocomial settings. Considered as one of the greatest threats to public health, the spread of bacteria drug resistance and the lack of effective alternative treatment options remains problematic. Herein, we report a promising strategy to combat Gram-negative resistant strains consisting of the combination of a macrolide antibiotic with a polyaminoisoprenyl adjuvant derivative leading to a significant decrease of antibiotic resistance.

Keywords: Gram-negative bacterial strains; antibiotic adjuvants; macrolide antibiotics; outer membrane; polyamines; polyaminoisoprenyl derivatives.

MeSH terms

  • Adjuvants, Pharmaceutic / pharmacology
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacteria*
  • Macrolides / pharmacology
  • Macrolides / therapeutic use
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Adjuvants, Pharmaceutic

Grants and funding

This research received no external funding.